CCL5 and neoplasm: Recent scRNA-seq studies on T-cells within PDAC patients have reported T-cell marker genes in CD8+ Tcm, CD4+ Tem, and γδT cells, and noted that the CCL5/SDC1 receptor–ligand interactions in tumor-infiltrating T-cells could promote tumor cell migration [74,75].